These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 12450704)

  • 1. The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol.
    Spooner ET; Desai RV; Mori C; Leverone JF; Lemere CA
    Vaccine; 2002 Dec; 21(3-4):290-7. PubMed ID: 12450704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.
    Petrushina I; Davtyan H; Hovakimyan A; Davtyan A; Passos GF; Cribbs DH; Ghochikyan A; Agadjanyan MG
    Mol Ther; 2017 Jan; 25(1):153-164. PubMed ID: 28129111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA prime-protein boost increased the titer, avidity and persistence of anti-Abeta antibodies in wild-type mice.
    Davtyan H; Mkrtichyan M; Movsesyan N; Petrushina I; Mamikonyan G; Cribbs DH; Agadjanyan MG; Ghochikyan A
    Gene Ther; 2010 Feb; 17(2):261-71. PubMed ID: 19865176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β oligomer specificity mediated by the IgM isotype--implications for a specific protective mechanism exerted by endogenous auto-antibodies.
    Lindhagen-Persson M; Brännström K; Vestling M; Steinitz M; Olofsson A
    PLoS One; 2010 Nov; 5(11):e13928. PubMed ID: 21085663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA epitope vaccine containing complement component C3d enhances anti-amyloid-beta antibody production and polarizes the immune response towards a Th2 phenotype.
    Movsesyan N; Mkrtichyan M; Petrushina I; Ross TM; Cribbs DH; Agadjanyan MG; Ghochikyan A
    J Neuroimmunol; 2008 Dec; 205(1-2):57-63. PubMed ID: 18838175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits.
    Acero G; Manoutcharian K; Vasilevko V; Munguia ME; Govezensky T; Coronas G; Luz-Madrigal A; Cribbs DH; Gevorkian G
    J Neuroimmunol; 2009 Aug; 213(1-2):39-46. PubMed ID: 19545911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with amyloid-beta attenuates inclusion body myositis-like myopathology and motor impairment in a transgenic mouse model.
    Kitazawa M; Vasilevko V; Cribbs DH; LaFerla FM
    J Neurosci; 2009 May; 29(19):6132-41. PubMed ID: 19439591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer disease.
    Basi GS; Feinberg H; Oshidari F; Anderson J; Barbour R; Baker J; Comery TA; Diep L; Gill D; Johnson-Wood K; Goel A; Grantcharova K; Lee M; Li J; Partridge A; Griswold-Prenner I; Piot N; Walker D; Widom A; Pangalos MN; Seubert P; Jacobsen JS; Schenk D; Weis WI
    J Biol Chem; 2010 Jan; 285(5):3417-27. PubMed ID: 19923222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres.
    Curvino EJ; Roe EF; Freire Haddad H; Anderson AR; Woodruff ME; Votaw NL; Segura T; Hale LP; Collier JH
    Nat Biomed Eng; 2024 May; 8(5):628-649. PubMed ID: 38012308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges.
    Jiskoot W; Kijanka G; Randolph TW; Carpenter JF; Koulov AV; Mahler HC; Joubert MK; Jawa V; Narhi LO
    J Pharm Sci; 2016 May; 105(5):1567-1575. PubMed ID: 27044944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic dissection of glutathione S-transferase omega-1: identification of novel downstream targets and Alzheimer's disease pathways.
    Jia Y; Gao MD; Liu YF; Lu L; Chen G; Chen Y
    Neural Regen Res; 2022 Nov; 17(11):2452-2458. PubMed ID: 35535896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against Aβ42 fibrils distinguish multiple aggregation state polymorphisms in vitro and in Alzheimer disease brain.
    Hatami A; Albay R; Monjazeb S; Milton S; Glabe C
    J Biol Chem; 2014 Nov; 289(46):32131-32143. PubMed ID: 25281743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.
    Liu B; Frost JL; Sun J; Fu H; Grimes S; Blackburn P; Lemere CA
    J Neurosci; 2013 Apr; 33(16):7027-37. PubMed ID: 23595760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's therapeutics: translation of preclinical science to clinical drug development.
    Savonenko AV; Melnikova T; Hiatt A; Li T; Worley PF; Troncoso JC; Wong PC; Price DL
    Neuropsychopharmacology; 2012 Jan; 37(1):261-77. PubMed ID: 21937983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
    Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
    J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like peptide vaccines against Abeta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant.
    Li QY; Gordon MN; Chackerian B; Alamed J; Ugen KE; Morgan D
    J Neuroimmune Pharmacol; 2010 Mar; 5(1):133-42. PubMed ID: 20066498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramembranous fragment of amyloid-beta: A potential immunogen for Alzheimer's disease immunotherapy.
    Zhang S; Wu L; Liu F; Huang B; Huang D; Yang L; Peng Z
    Neurochem Res; 2009 Nov; 34(11):1889-95. PubMed ID: 19347579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination strategies for Alzheimer's disease: A new hope?
    Woodhouse A; Dickson TC; Vickers JC
    Drugs Aging; 2007; 24(2):107-19. PubMed ID: 17313199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting with intranasal dendrimeric Abeta1-15 but not Abeta1-15 peptide leads to an effective immune response following a single injection of Abeta1-40/42 in APP-tg mice.
    Seabrook TJ; Jiang L; Thomas K; Lemere CA
    J Neuroinflammation; 2006 Jun; 3():14. PubMed ID: 16753065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model.
    Fukuchi K; Accavitti-Loper MA; Kim HD; Tahara K; Cao Y; Lewis TL; Caughey RC; Kim H; Lalonde R
    Biochem Biophys Res Commun; 2006 May; 344(1):79-86. PubMed ID: 16630540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.